Abstract
Insulin secretagogues such as sulphonylureas cause insulin release irrespective of the prevailing glucose concentration. Enhancing insulin secretion through a glucose-dependent mechanism is an attractive, novel therapeutic approach that can circumvent some of the unwanted effects of sulphonylureas—principally weight gain and hypoglycaemia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2012 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Krentz, A. (2012). Recently Introduced and Emerging Classes of Glucose-Lowering Drugs. In: Drug Therapy for Type 2 Diabetes. Springer Healthcare, Heidelberg. https://doi.org/10.1007/978-1-908517-77-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-908517-77-7_3
Published:
Publisher Name: Springer Healthcare, Heidelberg
Print ISBN: 978-1-908517-64-7
Online ISBN: 978-1-908517-77-7
eBook Packages: MedicineMedicine (R0)